Better Therapeutics Total Liabilities

Better Therapeutics posts a total liabilities of $21M as of September 2023. That compares with $21M in the prior-year period — down 1.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Better Therapeutics's total liabilities was $21M. The latest reading is $21M — a 1.5% year-over-year decrease (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Better Therapeutics's financial statement story. At $21M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BTTX's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Better Therapeutics's other metric pages and overview cover the third.